Withdrawn

Treatment Response to Hydroxychloroquine, Lopinavir–Ritonavir, and Antibiotics for Moderate COVID-19: A First Report on the Pharmacological Outcomes from South Korea

Min Seo Kim, Soon-Woo Jang, Yu-Kyung Park, Bong-Ok Kim, Tae-Ho Hwang, Seok Ho Kang, Won Jun Kim, Park Sung Kyu, Hea-Woon Park, Wonjong Yang, Joonyoung Jang, Min Ho An
doi: https://doi.org/10.1101/2020.05.13.20094193

Data Availability

A retrospective cohort study of 358 patients with laboratory-confirmed SARS Cov 2 infection hospitalized in Korea Workers Compensation and Welfare Service Daegu Hospital was conducted

Back to top
Posted June 14, 2020.
Download PDF
Data/Code
Email
Treatment Response to Hydroxychloroquine, Lopinavir–Ritonavir, and Antibiotics for Moderate COVID-19: A First Report on the Pharmacological Outcomes from South Korea
Min Seo Kim, Soon-Woo Jang, Yu-Kyung Park, Bong-Ok Kim, Tae-Ho Hwang, Seok Ho Kang, Won Jun Kim, Park Sung Kyu, Hea-Woon Park, Wonjong Yang, Joonyoung Jang, Min Ho An
medRxiv 2020.05.13.20094193; doi: https://doi.org/10.1101/2020.05.13.20094193
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area